Government report finds employers likely to drop insurance; Merck suffers less than rivals on health reform;

> Not everyone agrees with a recent national survey that found most employers don't plan to ditch health insurance for their employees. Price increases resulting from the new health reform law could in fact prompt some employers to stop providing healthcare benefits to employees, according to a new report from Richard Foster, the chief actuary of the Centers for Medicare and Medicaid Services. FierceHealthPayer

> There's one Big Pharma that's not losing much to healthcare reform, relatively speaking. Merck says higher Medicaid rebates will cost it $170 million this year, and next year's tab will run $300 million to $350 million as Medicare discounts kick in. That's less than 1 percent of the company's global sales, and it's far less than estimates from other drugmakers. FiercePharma

> Hospital Impact's Paul Roemer is tired of hospitals not knowing the answers to basic questions like "What treatments are going to be provided to me during my visit?" and "How much will my visit cost?". Instead, he suggests hospitals adopt an "assembly-line" approach. Commentary

And Finally... While his actions are deplorable, the bigger mystery is why did this guy hang out at the scene of the crime? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.